PATENT CLAIM ANALYSIS

Application Number: 16136926
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "093200"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Claim (Index 1):
An AAV vector genome comprising, in order:\n a) a 5\u2032 inverted terminal repeat (ITR), wherein said 5\u2032 ITR is 141 nucleotides in length; b) an AADC sequence region, said AADC sequence region comprising a nucleotide sequence encoding SEQ ID NO: 1, c) a 3\u2032 ITR, wherein said 3\u2032 ITR is 141 nucleotides in length.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 97.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15524986', '14242648', '15191357', '11102521', '15526697']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6589835875169862
- 35 USC 102 Novelty (BERT): 0.5357988349958244
- Combined Prediction Score: 0.64666511226487
- Mean Citation Score: 240.685998
- Max Citation Score: 367.53546
- Similarity Product: 289.7810780159104

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test